Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathon R Campbell

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
The American Journal of Tropical Medicine and Hygiene|January 18, 2019
What's Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant TuberculosisJonathon R Campbell, Dick Menzies
American Journal of Epidemiology|July 3, 2021
Invited Commentary: The Role of Tuberculosis Screening Among Migrants to Low-Incidence Settings in (Not) Achieving EliminationJonathon R Campbell, Kevin Schwartzman
Nature Medicine|April 22, 2026
The ghost of tuberculosis pastAnete Trajman, Jonathon R Campbell
The Lancet. Infectious Diseases|November 4, 2019
What makes a score a winner?Jonathon R Campbell, Dick Menzies
Clinical Chemistry and Laboratory Medicine|October 2, 2012
Metal release from hip prostheses: cobalt and chromium toxicity and the role of the clinical laboratoryJonathon R Campbell, Mathew P Estey
Lancet (London, England)|March 23, 2020
No time to waste: preventing tuberculosis in childrenJonathon R Campbell, Mayara L Bastos
BMJ (Clinical Research Ed.)|March 12, 2020
Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysisJonathon R Campbell, Nicholas Winters, Dick Menzies
Applied Health Economics and Health Policy|July 2, 2015
A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis InfectionJonathon R Campbell, Thenuga Sasitharan, Fawziah Marra
Plos Medicine|June 7, 2019
Treatment of latent infection to achieve tuberculosis elimination in low-incidence countriesJonathon R Campbell, David Dowdy, Kevin Schwartzman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Effect of Intermittency on Treatment Outcomes in Pulmonary Tuberculosis: An Updated Systematic Review and MetaanalysisJames C Johnston, Jonathon R Campbell, Dick Menzies
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
The American Journal of Tropical Medicine and Hygiene|January 18, 2019
What's Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant TuberculosisJonathon R Campbell, Dick Menzies
American Journal of Epidemiology|July 3, 2021
Invited Commentary: The Role of Tuberculosis Screening Among Migrants to Low-Incidence Settings in (Not) Achieving EliminationJonathon R Campbell, Kevin Schwartzman
Nature Medicine|April 22, 2026
The ghost of tuberculosis pastAnete Trajman, Jonathon R Campbell
The Lancet. Infectious Diseases|November 4, 2019
What makes a score a winner?Jonathon R Campbell, Dick Menzies
Clinical Chemistry and Laboratory Medicine|October 2, 2012
Metal release from hip prostheses: cobalt and chromium toxicity and the role of the clinical laboratoryJonathon R Campbell, Mathew P Estey
Lancet (London, England)|March 23, 2020
No time to waste: preventing tuberculosis in childrenJonathon R Campbell, Mayara L Bastos
BMJ (Clinical Research Ed.)|March 12, 2020
Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysisJonathon R Campbell, Nicholas Winters, Dick Menzies
Applied Health Economics and Health Policy|July 2, 2015
A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis InfectionJonathon R Campbell, Thenuga Sasitharan, Fawziah Marra
Plos Medicine|June 7, 2019
Treatment of latent infection to achieve tuberculosis elimination in low-incidence countriesJonathon R Campbell, David Dowdy, Kevin Schwartzman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Effect of Intermittency on Treatment Outcomes in Pulmonary Tuberculosis: An Updated Systematic Review and MetaanalysisJames C Johnston, Jonathon R Campbell, Dick Menzies
Pageof 10